MedTrace Logo

Intervention for Self-regulation to Physical Exercise in People With Fibromyalgia

NCT04655053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2022-05-25

No results posted yet for this study

Summary

This work is part of a broader research with women with fibromyalgia. The aim of this study is to establish the effectiveness of implementation intentions to manage the preference for avoiding pain and fatigue and stop walking exercise, versus to maintain the approximate behavior (walking), taking into account high and low pain catastrophizing conditions.

Conditions

  • Fibromyalgia

Interventions

BEHAVIORAL

Goal intention

Researcher instructs participants to adopt and learn the goal intention requesting them to write it three times and verbally repeat once.

BEHAVIORAL

Implementation intention to initiate the behavior

Researcher instructs participants to adopt and learn the goal intention and the plan requesting them to write it three times and verbally repeat once.

BEHAVIORAL

Implementation intention to manage the goal preference (avoiding behavior or not)

Researcher instructs participants to adopt and learn the goal intention and the plan requesting them to write it three times and verbally repeat once.

Sponsors & Collaborators

  • Ministerio de Economía y Competitividad, Spain

    collaborator OTHER_GOV

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • María-Ángeles Pastor-Mira, PhD · Universidad Miguel Hernández

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2021-04-29
Completion
2021-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04655053 on ClinicalTrials.gov